Jimmy Moses Tindamanyire

Dr. Jimmy Moses Tindamanyire

Department of Biological Sciences, Faculty of Science, Kabale University, Kabale, Uganda
orcid
Open for collaboration

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in ISPRS Journal of Photogrammetry and Remote Sensing
Verified
Journal Article
Open access
PSPriyakant Sinha
Priyakant Sinha
Andrew RobsonAndrew Robson
Andrew Robson
DSDerek Schneider
Derek Schneider
TKTalip Kilic
Talip Kilic
HMHarriet Kasidi Mugera
Harriet Kasidi Mugera
Jimmy Moses TindamanyireJimmy Moses Tindamanyire
Jimmy Moses Tindamanyire

10 June 2025 in Plant Biotechnology Journal
Verified
Journal Article
Open access
SBStephen Buah
Stephen Buah
Jimmy Moses TindamanyireJimmy Moses Tindamanyire
Jimmy Moses Tindamanyire
PNPriver Namanya
Priver Namanya
JKJerome Kubiriba
Jerome Kubiriba
GAGeoffrey Arinaitwe
Geoffrey Arinaitwe
WTWilberforce Tushemereirwe
Wilberforce Tushemereirwe
Summary: Biofortification of staple crops is a sustainable strategy to deliver essential micronutrients to impoverished populations in developing countries. Banana is a highly valued crop consumed by over 75% of Ugandans. However, the starchy green cooking bananas have very low levels of pro‐vitamin A (PVA) and heavy dietary reliance on them has been associated with vitamin A deficiency (VAD). Two banana cultivars, hybrid M9 and Nakitembe, were selected for PVA biofortification. A phytoene synthase 2a (MtPsy2a) gene was transformed into the selected cultivars under the control of the constitutive maize polyubiquitin1 promoter or the banana fruit‐preferred ACC oxidase (ACO) promoter. Plants were regenerated on selective media and putatively transgenic plants confirmed by PCR. A total of 356 and 162 transgenic events for M9 and Nakitembe, respectively, were planted in a confined field trial (CFT). Transgenic plants were assessed against non‐transformed controls. Selection was based on phenotype, cycle time, yield, β‐carotene equivalents (β‐CE) and transgene copy number. There were no significant variations in cycle time, but some phenotypic differences were observed between transgenic and non‐transgenic controls. Transgenic fruits had yellow to orange fruit pulps, unlike pulp from non‐transgenic controls that were paler. On average, fruit from transgenic M9 and Nakitembe accumulated fourfold and threefold more β‐CE than non‐transgenic controls, respectively. Five elite lines each of M9 and Nakitembe have been selected for national agronomic performance trials that will aid the selection of lead events to be considered for environmental release.

16 September 2025 in Frontiers in Plant Science
Verified
Journal Article
Open access
PDF file
FKFrank Kalungi
Frank Kalungi
JMJulius Mulindwa
Julius Mulindwa
AMAbubakar Sadik Mustafa
Abubakar Sadik Mustafa
PNPriver Bwesigye Namanya
Priver Bwesigye Namanya
JKJerome Kubiriba
Jerome Kubiriba
Jimmy Moses TindamanyireJimmy Moses Tindamanyire
Jimmy Moses Tindamanyire
East African highland bananas (EAHBs), locally referred to as “matooke”, are an important staple crop in Uganda. The EAHBs have a triploid genome (AAA) with a large phenotypic diversity in the Great Lakes region of Africa and are challenged by both abiotic and biotic factors. The EAHBs have been improved through conventional breeding and genetic engineering though facing challenges such as genetic drag of unfavorable traits and complex regulatory processes, respectively. Therefore, a more precise approach for crop improvement such as genome editing is highly recommended. In the current study, we assessed the feasibility and applicability of the CRISPR/ Cas 9 mediated-genome editing in EAHBs. Two sgRNAs were designed from the Nakitembe phytoene desaturase ( PDS ) gene and used to edit the PDS gene in Nakitembe (NKT) and NAROBan5 (M30) cultivars. A total of 47 NKT and 130 M30 events were regenerated via agrobacterium -mediated transformation of banana embryogenic cell suspensions. Up to 100% and 94.6% albinism rates were observed in Nakitembe and M30 cultivars respectively with additional albino-variegated and variegated phenotypes observed in M30 only. Carotenoid analysis revealed a significant reduction of total carotenoid content in edited events with all complete albinos showing no detectable carotenoids implying that the carotenoid biosynthetic pathway was effectively disrupted. Sequence analysis revealed that all of the edited events had frameshift mutations leading to PDS disruption. Overall, this study presents the first report of CRISPR/ Cas 9 genome editing in EAHBs and more interestingly on a hybrid, M30 showing high precision and efficiency. This validated genome editing system provides a robust platform for targeted EAHB improvement.

11 December 2025 in Vegetos
Verified
Journal Article
Open access
PDF file
FKFrank Kalungi
Frank Kalungi
Jimmy Moses TindamanyireJimmy Moses Tindamanyire
Jimmy Moses Tindamanyire
VNValentine Otang Ntui
Valentine Otang Ntui
AMAbubakar Sadik Mustafa
Abubakar Sadik Mustafa
BNBarbara Nerima
Barbara Nerima
Godwin AnywarGodwin Anywar
Godwin Anywar
Plant genetic engineering goes back to over 40 years ago with the first genetically modified tobacco expressing the nopaline synthase gene. Since then, genetic engineering has emerged as an important technology as various sectors have included it in their strategic plans with potential impact on healthcare, agriculture and industry. One important aspect is the engineering of plants as bioreactors for production of vaccines, monoclonal antibodies, pesticides, orphan drugs, dyes and many other recombinant novel products. This process is referred to as plant molecular pharming. Plant molecular pharming has numerous benefits over conventional methods such as the use of animal cell lines and prokaryotic systems to produce recombinant products. These benefits include cost effectiveness, rapid and high mass production, easy scalability, accessibility and sustainability. Some African countries such as South Africa have adopted plant molecular pharming and have increased human and infrastructural capacity development, collaborations, and public sensitisation coupled with enabling policies and regulatory frameworks. However, in most of Africa, the sector faces numerous challenges including the lack of funding and expertise, low public acceptance, and poor to inadequate polices and regulatory frameworks. Despite the caveats surrounding the technology, it remains a significantly important tool for addressing global health challenges and fostering biotechnology innovations. Therefore, this review explores plant molecular pharming methods and associated products, advantages, strategies taken to improve the technology, regulatory and social- economic issues surrounding the technology in Africa.

29 January 2026 in Frontiers in Plant Science
Verified
Journal Article
Open access
FKFrank Kalungi
Frank Kalungi
JMJulius Mulindwa
Julius Mulindwa
SMSamwel Kariuki Muiruri
Samwel Kariuki Muiruri
VNValentine Otang Ntui
Valentine Otang Ntui
AMAbubakar Sadik Mustafa
Abubakar Sadik Mustafa
Jimmy Moses TindamanyireJimmy Moses Tindamanyire
Jimmy Moses Tindamanyire